Oral Vitamin K—US Newborns Need an FDA-Approved Option

20 Apr 20264 min read0 viewsJournal Feed

GIST

This Viewpoint describes rising rates of parent declination of intramuscular vitamin K prophylaxis for newborns and recommends development of a US Food and Drug Administration (FDA)–approved oral formulation.

Clinical Editorial

Summary

JAMA Pediatrics published a clinical update in Research Highlights on 20 Apr 2026. The item focuses on Oral Vitamin K—US Newborns Need an FDA-Approved Option. Open the detail page to review the full original feed content.